IP Library Granted Patent US 9,364,283
Granted Patent B2
US 9,364,283 · App. 13/558,506 · Granted Jun 14, 2016

Method and apparatus for gastrointestinal tract ablation to achieve loss of persistent and/or recurrent excess body weight following a weight loss operation

Inventors: David S. Utley (Redwood City, CA); John de Csepel (New York, NY)
Assignee: Covidien LP
A61B18/1492A61B18/0218A61B2018/0016A61B2018/0022A61B2018/00214A61B2018/00482A61B2018/00654A61B2018/00702A61B2018/00791A61B2018/00875A61B2018/00898A61B2018/0262A61B2018/124A61B2018/1497
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,364,283
App. No.
13/558,506
Granted
Jun 14, 2016
Kind
B2
Abstract

Devices and methods are provided for ablational treatment of regions of the digestive tract in post-bariatric surgery patients who fail to achieve or maintain the desired weight loss. Bariatric procedures include Roux-en-Y gastric bypass, biliopancreatic diversion, and sleeve gastrectomy. These procedures reconstruct gastrointestinal tract features, creating pouches, stoma, and tubes that restrict and/or divert the digestive flow. Post-surgical dilation of altered structures is common and diminishes their bariatric effectiveness. Ablation of compromised structures can reduce their size and compliance, restoring bariatric effectiveness. Ablation, as provided the invention, starts at the mucosa and penetrates deeper into the gastrointestinal wall in a controlled manner. Control may also be provided by a fractional ablation that ablates some tissue within a target region and leaves a portion substantially unaffected. Embodiments of the device include an ablational electrode array that spans 360 degrees and an array that spans an arc of less than 360 degrees.

Claims (20)

1. A method of treating a gastrointestinal tract feature formed by a bariatric surgical procedure that has become dilated comprising:

identifying a target area of the surgically-formed gastrointestinal feature;

positioning a therapy device in the gastrointestinal tract adjacent to a target area on the dilated feature; and

performing a non-surgical reduction therapy on the target area of the dilated feature.

2. The method of claim 1 wherein the identifying step is performed endoscopically.

3. The method of claim 1 wherein the identifying step, the positioning step, and the performing step are conducted during a single endoscopic procedure.

4. The method of claim 1 further comprising:

inserting an instrument having a reduction therapy device mounted thereon into the gastrointestinal tract before the identifying step; and

removing the instrument after the performing step.

5. The method of claim 1 wherein performing the non-surgical reduction therapy on the surgically-formed gastrointestinal feature includes applying energy to the target area.

6. The method of claim 5 wherein the energy is radiofrequency energy.

7. The method of claim 5 wherein applying energy to the target includes controlling the delivery of energy across the tissue surface in the target area.

8. The method of claim 5 wherein applying energy to the target area includes controlling the depth of delivery of energy into tissue layers in the target area.

9. The method of claim 5 wherein applying energy to the target area includes applying energy more than once.

10. The method of claim 5 wherein applying energy to the target area includes applying energy to more than one site on the gastrointestinal feature.

11. The method of claim 1 wherein performing a non-surgical reduction therapy surgically-formed gastrointestinal feature includes applying cryogenic treatment to the target area.

12. The method of claim 11 wherein applying the cryogenic treatment includes spraying a cryogenic fluid on the target area.

13. The method of claim 11 wherein applying the cryogenic treatment includes drawing heat from the target area into a cryogenic fluid contained in the device.

14. The method of claim 1 wherein the positioning step further includes moving an ablation structure of the device so as to make therapeutic contact with a target area on the dilated feature.

15. The method of claim 14 wherein moving the ablation structure includes any of inflating a balloon member, expanding a deflection member, moving a deflection member, or expanding an expandable member.

Assignments (5)
AMENDMENT TO THE ASSIGNMENT Recorded Apr 24, 2013
From: COVIDIEN LP, FORMERLY KNOWN AS TYCO HEALTHCARE GROUP LP AS SUCCESSOR TO BARRX MEDICAL LLC
To: COVIDIEN LP, FORMERLY KNOWN AS TYCO HEALTHCARE GROUP LP
Reel/Frame 030292/0372 →
CHANGE OF NAME Recorded Apr 5, 2013
From: BARRX MEDICAL, INC.
To: BARRX MEDICAL LLC
Reel/Frame 030163/0335 →
CHANGE OF NAME Recorded Oct 2, 2012
From: TYCO HEALTHCARE GROUP LP
To: COVIDIEN LP
Reel/Frame 029065/0403 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2012
From: UTLEY, DAVID S.; DE CSEPEL, JOHN
To: BARRX MEDICAL LLC
Reel/Frame 028672/0335 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2012
From: BARRX MEDICAL LLC
To: TYCO HEALTCARE GROUP LP
Reel/Frame 028672/0600 →
Continuity (3)
Division 12167902 · Jul 3, 2008
Provisional Application 60958543 · Jul 6, 2007
Related Publication 20120289952A1 · Nov 15, 2012